Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
31,034,642
-
Share change
-
+290,851
-
Total reported value
-
$1,010,169,305
-
Price per share
-
$32.55
-
Number of holders
-
122
-
Value change
-
+$9,811,765
-
Number of buys
-
64
-
Number of sells
-
42
Institutional Holders of GENOMIC HEALTH INC - COM (GHDX) as of Q2 2017
As of 30 Jun 2017,
GENOMIC HEALTH INC - COM (GHDX) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,034,642 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Camber Capital Management LLC, BlackRock Inc., VANGUARD GROUP INC, COLUMBIA WANGER ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, LOOMIS SAYLES & CO L P, STATE STREET CORP, SCHWAB CHARLES INVESTMENT MANAGEMENT INC, and EAGLE ASSET MANAGEMENT INC.
This page lists
122
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.